WELCOME TO The government REPORT
Judicial Appointments Commission
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
GOVERNMENT BUSINESS,GOVERNMENT INSURANCE
Voxtur | July 06, 2022
Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) ("Voxtur" or the "Company"), a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that, further to the news release issued on June 9, 2022, it has completed the arm's length acquisition of Municipal Tax Equity Consultants Inc. ("MTEC") and its associated entity, MTAG Paralegal Professional Corp., acquired MTE Paralegal Professional Co...
Dcode | April 08, 2020
Government technology accelerator Dcode has added another offering to help startups find work with federal agencies: venture capital. Dcode recently launched Dcode Capital as an “invitation-only network of angel investors, VCs, and technology and government legends” to invest in larger rounds of funding for tech companies serving the federal government. For now, those companies are ones that have previously participated in the Dcode accelerator program....
CoLab Software | January 13, 2022
CoLab Software has signed a contract with the Government of Canada that enables the Department of National Defence (DND) to test CoLab’s collaborative engineering software. Funded under the Canadian government’s Innovative Solutions Canada Testing Stream, the $412,000 CAD contract allows the Naval Material Technology Management (NMTM) section of the DND to evaluate CoLab’s usefulness for modernizing their engineering design review processes. CoLab’s web-based app provides...
Merck | December 22, 2021
Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United Kingdom Government will purchase an additional 1.75 million patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine. In the U.K., LAGEVRIO® is the planned trademark for molnupiravir; the trademark for molnupiravir in other countries has not been approved. With this additional procurement agreement, which follows a previously announced...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE